Share this video  

SITC 2021 | The future of monotherapies in melanoma

Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, shares his thoughts on the future of monotherapies in melanoma. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter